آخر تحديث :
22/08/2024
Infostab
قائمة المركبات
ملخص القوائم
ابحث عن التوافق
جدول توافق موقع ص
مراجع
فرق البحث
valistab
الملصق
الروابط
الرعاة
الكتاب
دليل المستخدم
النشرة الإخبارية
Daunorubicin hydrochloride
التركيب الكيميائي
حجز الاسم التجاري
تحذير الأسماء التجاريه المختلفه قد تحتوي علي محتوي إضافات مختلفة حسب الدوله و المعمل
Cerubidin
الدنمارك, السويد, النرويج, ايرلندا, بريطانيا العظمي
Cerubidine
المغرب, الولايات المتحدة, بلجيكا, تركيا, تشيلي, تونس, سويسرا, فرنسا, كندا, لوكسمبورغ, هولندا
D Blastin
المغرب
Daunac
كولومبيا
Daunobin
الهند
Daunoblastin
ألمانيا, النمسا
Daunoblastina
إسبانيا, إيران, إيطاليا, العربية السعودية, فنزويلا, هنغاريا, يونان
Daunocin
الهند, بيرو, ماليزيا
Daunogobbi
الأرجنتين
Daunomed
الهند, بيرو
Daunomycin
الهند
Daunoplus
الهند
Daunorubicin
أستراليا, الولايات المتحدة, بريطانيا العظمي, زيلاندا الجديدة, كندا
Daunorubicina
الإكوادور, المكسيك, بيرو, تشيلي, كولومبيا
Daunorubitec
الهند
Daunoside
الهند
Daunotec
الهند, فنزويلا
Daurocina
تشيلي
Epodoxo
بيرو
Maxidauno
الأرجنتين, الإكوادور
Oncodaunotec
كولومبيا
Rubilem
المكسيك
Runabicon
المكسيك, كولومبيا
Zuleb
المكسيك
مراجع : Daunorubicin hydrochloride
نوع
منشور
3
مجلة
Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
81
مجلة
Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678.
84
مجلة
Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
99
مجلة
Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
148
مجلة
Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I.
Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.
Pharm Weekbl [Sci] 1992 ; 14: 365-369.
150
مجلة
Aujoulat P, Coze C, Braguer D, Raybaud C.
Physicochemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimens.
J Pharm Clin 1993 ; 12: 31-35.
152
مجلة
Chevrier R, Sautou V, Pinon V, Demecop F, Chopineau J.
Stability and compatibility of a mixture of the anti-cancer drugs etoposide, cytarabine and daunorubicine for infusion.
Pharm Acta Helv 1995 ; 70: 141-148.
169
مجلة
Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
244
مجلة
Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
249
مجلة
Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
307
مجلة
Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
334
مجلة
Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
492
مجلة
Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189.
632
مجلة
Beijnen JH, Rosing H, De Vries PA, Underberg WJM.
Stability of anthracycline antitumour agents in infusion fluids.
J Parenter Sci Technol 1985 ; 39: 220-222.
643
مجلة
Seargeant LE, Kobrinsky NL, Sus CJ, Nazeravich DR.
In vitro stability and compatibility of daunorubicin, cytarabine, and etoposide.
Cancer Treat Rep 1987 ; 71: 1189-1192.
686
مجلة
Wood MJ, Irwin WJ, Scott DK.
Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags.
J Clin Pharm Ther 1990 ; 15: 279-289.
905
مجلة
Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
1265
مجلة
Wood MJ, Irwin WJ, Scott DK.
Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography.
J Clin Pharm Ther 1990 ; 15: 291-300.
1284
مجلة
Williams BA, Tritton TR.
Photoinactivation of anthracyclines.
Photochem Photobiol 1981 ; 34: 131-134.
1410
مجلة
Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1423
مجلة
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1520
مختبر
Etude de stabilité des médicaments en Ecoflac®
B Braun 2001
1625
مجلة
Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1897
مجلة
Sautou-Miranda V, Brigas F, Thibault M, Chopineau J.
Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage.
EJHP 2001 ; 7, 3: 108-115.
1982
مجلة
Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2247
مجلة
Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
3438
مجلة
Respaud R, Quenum L, Plichon C, Tournamille J.F, Gyan E, Antier D, Viaud-Massuard M.C.
A stability-indicating, ion-pairing, reversed-phase liquid chromatography method for studies of daunorubicin degradation in i.v. infusion fluids.
J Pharm Biomed Anal 2013 ; 83 : 164-170.
3474
مختبر
Fluorouracil - Summary of Product Characteristics
Accord Healthcare Limited 2009
3540
مختبر
Heparin sodium - Summary of Product Characteristics.
Wockhardt 2010
3604
مختبر
Daunorubicine (Cérubidine®) - Résumé des caractéristiques du produit
Sanofi Aventis France 2012
3668
مختبر
Dexamethasone - Summary of Product Characteristics
Hospira 2015
Mentions Légales